Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 244,834 | 143,091 | 54,123 | 65,061 | 4,570 |
| Operating Income | -244,834 | -143,091 | -54,123 | -65,061 | -4,570 |
| Interest Expense | 7,248 | 0 | 0 | 0 | 0 |
| Other Income | 22,372 | 22,129 | 10,138 | 592 | 28 |
| Pre-tax Income | -229,710 | -120,962 | -43,985 | -64,470 | -4,543 |
| Income Tax | 611 | 282 | 94 | 36 | N/A |
| Net Income Continuous | -230,321 | -121,244 | -44,079 | -64,506 | -4,543 |
| Minority Interests | -3,003 | -2,308 | -8,072 | -14,533 | N/A |
| Net Income | $-227,318 | $-118,936 | $-36,007 | $-49,973 | $-4,543 |
| EPS Basic Total Ops | -3.53 | -1.89 | -0.73 | -1.70 | -0.31 |
| EPS Basic Continuous Ops | -3.57 | -1.93 | -0.90 | -2.20 | -1.58 |
| EPS Diluted Total Ops | -3.53 | -1.89 | -0.73 | -1.70 | -0.31 |
| EPS Diluted Continuous Ops | -3.57 | -1.93 | -0.90 | -2.20 | -1.58 |
| EPS Diluted Before Non-Recurring Items | -3.53 | -1.89 | -0.73 | -1.70 | N/A |
| EBITDA(a) | $-242,218 | $-141,706 | $-53,753 | $-64,897 | $-4,570 |